Table 2 Prescription of monotherapies according to age group and gender
Antihypertensives | Total | Gender | Age group [years] | ||||
|---|---|---|---|---|---|---|---|
Male | Female | Under 40 | 40-59 | 60-79 | 80 or older | ||
[N (%)] | [n (%)] | [n (%)] | [n (%)] | [n (%)] | [n (%)] | [n (%)] | |
CCBs1 | 285 (16.7) | 101 (16.2) | 184 (17.0) | 12 (19.0) | 47 (9.1) | 148 (18.5) | 78 (23.7) |
- with CAM2 | 9 | 2 | 7 | - | 1 | 6 | 2 |
Diuretics | 267 (15.7) | 88 (14.1) | 179 (16.6) | 9 (14.3) | 71 (13.7) | 107 (13.4) | 80 (24.3) |
- with CAM | 28 | 8 | 20 | 1 | 16 | 9 | 2 |
Beta-blockers | 523 (30.7) | 181 (29.0) | 342 (31.7) | 23 (36.5) | 204 (39.5) | 224 (28.1) | 72 (21.9) |
- with CAM | 27 | 7 | 20 | 1 | 8 | 15 | 3 |
ACE inhibitors | 409 (24.0) | 158 (25.3) | 251 (23.2) | 17 (27.0) | 106 (20.5) | 206 (25.9) | 80 (24.3) |
- with CAM | 23 | 3 | 20 | 1 | 6 | 10 | 6 |
Angiotensin II antagonists | 200 (11.7) | 91 (14.6) | 109 (10.1) | 1 (1.6) | 79 (15.3) | 104 (13.1) | 16 (4.9) |
- with CAM | 17 | 5 | 12 | - | 7 | 8 | 2 |
Alpha-1 blockers | 4 (0.2) | 2 (0.3) | 2 (0.2) | - | 3 (0.6) | 1 (0.1) | - |
- with CAM | 0 | - | - | - | - | - | - |
Antiadrenergic agents | 17 (1.0) | 4 (0.6) | 13 (1.2) | 1 (1.6) | 7 (1.4) | 6 (0.8) | 3 (0.9) |
- with CAM | - | - | - | - | - | - | - |
Total | 1705 (100) | 625 (100) | 1080 (100) | 63 (100) | 517 (100) | 796 (100) | 329 (100) |